Local Institution - 100

New York, New York 10065

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin Lymphoma

Studies at this site

• A Rollover Study of CC-122 — Running, not enrolling
• A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas — Stopped early